Materialise (MTLS) has released an update.
Materialise NV reported a 14.2% increase in total revenue for Q3 2024, reaching 68,652 kEUR, with notable growth in their Medical segment. Despite a decline in net profit compared to the previous year, the company achieved an 89% rise in Adjusted EBIT, indicating strong operational performance. Materialise continues to invest in future growth, maintaining confidence in meeting its full-year revenue and EBIT guidance.
For further insights into MTLS stock, check out TipRanks’ Stock Analysis page.
